Bodong Zhou
Overview
Explore the profile of Bodong Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Song Y, Zhou B, Yuan S, Gao S
Open Med (Wars)
. 2024 Sep;
19(1):20230893.
PMID: 39221034
Insulin-like growth factor binding protein 2 (IGFBP2) is overexpressed in tumor tissues of several malignancies, including pancreatic cancer. Because of its role in tumor progression, IGFBP2 has been investigated as...
2.
Liu J, Bai W, Zhou T, Xie Y, Yang B, Sun J, et al.
Gut
. 2023 Feb;
72(9):1722-1737.
PMID: 36828627
Objective: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal tumour with limited treatment options. Here, we identified syndecan binding protein (SDCBP), also known as syntenin1, as a novel targetable factor...
3.
Wang H, Jia R, Zhao T, Li X, Lang M, Lan C, et al.
Cancer Lett
. 2023 Feb;
558:216059.
PMID: 36813650
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and Authors. Following concerns raised in...
4.
Yuan S, Xu J, Zhou B, Zhou Y, Lang M, Cao J, et al.
Int J Biol Sci
. 2022 Feb;
18(3):911-922.
PMID: 35173526
Pancreatic cancer is a dismal malignancy with poor prognosis. In spite of progress in surgical technology, chemotherapy is still the cornerstone in the multi-disciplinary treatment. Albumin-bound paclitaxel is a first-line...
5.
Zhou B, Zhu W, Yuan S, Wang Y, Zhang Q, Zheng H, et al.
Thorac Cancer
. 2021 Dec;
13(3):369-379.
PMID: 34951127
Background: The purpose of this study was to explore the reason for guanine nucleotide binding-protein gamma subunit-4 (GNG4) overexpression and the relationship between GNG4 overexpression and the poor prognosis of...
6.
Zhou Y, Gao S, Zhou B, Yuan S, Ren H, Wang Y, et al.
Pancreatology
. 2021 Mar;
21(4):763-770.
PMID: 33712388
Background: FOLFIRINOX and gemcitabine plus albumin-bound paclitaxel (AG) regimens are recommended as first-line therapy for both locally advanced and metastatic pancreatic cancer. However, there were no specific markers to conduct...
7.
Xu J, Zheng H, Yuan S, Zhou B, Zhao W, Pan Y, et al.
Thorac Cancer
. 2019 Jul;
10(8):1702-1709.
PMID: 31268619
Background: ANLN has been identified as an actin-binding protein and previous studies have suggested that ANLN is associated with actin cytoskeletal dynamics. Lung adenocarcinoma is a poor prognosis tumor. Metastasis...
8.
Wang H, Jia R, Zhao T, Li X, Lang M, Lan C, et al.
Cancer Lett
. 2019 Mar;
453:10-20.
PMID: 30922919
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
This article has been retracted at the request of the Editor-in-Chief and Authors.
Following concerns raised in...
9.
Liu C, Shi J, Li Q, Li Z, Lou C, Zhao Q, et al.
Clin Sci (Lond)
. 2019 Feb;
133(5):645-663.
PMID: 30782607
Forkhead box protein M1 (FOXM1) was identified as an oncogenic transcription factor and master regulator of tumor progression and metastasis. FOXM1 expression often correlates with poor prognosis and chemotherapy resistance....
10.
Zhou B, Xu J, Tian Y, Yuan S, Li X
Thorac Cancer
. 2018 Aug;
9(10):1235-1240.
PMID: 30070037
Background: The purpose of the study was to investigate the association between radiomic features based on contrast-enhanced multidetector computed tomography (CT) and the Ki-67 proliferation index (PI) in patients with...